Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001434317 | SCV001637122 | likely benign | Intellectual disability, autosomal dominant 6; Developmental and epileptic encephalopathy, 27 | 2020-01-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002420982 | SCV002720507 | uncertain significance | Inborn genetic diseases | 2018-07-25 | criteria provided, single submitter | clinical testing | The c.2011-5T>C intronic variant results from a T to C substitution 5 nucleotides upstream from coding exon 9 in the GRIN2B gene. This nucleotide position is well conserved in available vertebrate species. Using the BDGP and ESEfinder splice site prediction tools, this alteration is not predicted to have any significant effect on this splice acceptor/donor site; however, direct evidence is unavailable. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |